Genetics of familial cardiomyopathies and arrhythmias

Swiss Medical Weekly

Volumn 132, Issue 29-30, 2002, Pages 401-407

  Keller, Dagmar I ^a   Carrier, Lucie ^a   Schwartz, Ketty ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Arrhythmias; Cardiomyopathies; Gene mutations; Genotype phenotype correlations; Inherited; Molecular cardiology

Indexed keywords

ION CHANNEL;

BRUGADA SYNDROME; CARDIOMYOPATHY; CATECHOLAMINERGIC SYSTEM; CLINICAL FEATURE; CORRELATION ANALYSIS; DISEASE COURSE; FAMILIAL DISEASE; GENE MUTATION; GENETIC ANALYSIS; GENETIC CODE; GENOTYPE; HEART ARRHYTHMIA; HEART DILATATION; HYPERTROPHIC CARDIOMYOPATHY; LONG QT SYNDROME; MOLECULAR GENETICS; PHENOTYPE; PROGNOSIS; SHORT SURVEY;

EID: 0037183373     PISSN: 14247860     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (50)

1. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies. Circulation 1996;93:841-2.
2. Maron BJ, Gardin JM, Flack JM, Gidding SS, Kurosaki TT, Bild DE. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary artery risk development in (young) adults. Circulation 1995;92:785-9.
3. Gollob MH, Green MS, Tang AS, Gollob T, Karibe A, Ali Hassan AS, et al. Identification of a gene responsible for familial Wolff-Parkinson-White syndrome. N Engl J Med 2001;344:1823-31.
4. Gollob MH, Seger JJ, Gollob TN, Tapscott T, Gonzales O, Bachinski L, et al. Novel PRKAG2 mutation responsible for the genetic syndrome of ventricular preexcitation and conduction system disease with childhood onset and absence of cardiac hypertrophy. Circulation 2001;104:3030-3.
5. Fung DC, Yu B, Littlejohn T, Trent RJ. An online locus-specific mutation database for familial hypertrophic cardiomyopathy. Hum Mutat 1999;14:326-32.
6. Richard P, Charron P, Carrier L, Ledeuil L, Dubourg O, Desnos M, et al. Distribution of disease genes in 102 genotyped families with hypertrophic cardiomyopathy. Circulation 2001;104 (suppl.):II-521.
7. Vignier N, Perrot A, Schulte HD, Richard P, Sebillon P, Schwartz K, et al. Cardiac myosin-binding protein C and familial hypertrophic cardiomyopathy: From mutations identification to human endomyocardial proteins analysis. Circulation 2001;104(suppl.):II-1.
8. Charron P, Carrier L, Dubourg O, Tesson F, Desnos M, Richard P, et al. Penetrance of familial hypertrophic cardiomyopathy. Genet Couns 1997;8:107-14.
9. Marian AJ, Roberts R. Molecular genetic basis of hypertrophic cardiomyopathy: Genetic markers for sudden cardiac death. J Cardiovasc Electrophysiol 1998;9:88-99.
10. Enjuto M, Francino A, Navarro-Lopez F, Viles D, Pare JC, Ballesta AM. Malignant hypertrophic cardiomyopathy caused by the Arg723Gly mutation in beta-myosin heavy chain gene. J Mol Cell Cardiol 2000;32:2307-13.
11. Niimura H, Bachinski LL, Sangwatanaroj S, Watkins H, Chudley AE, McKenna W, et al. Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy. N Engl J Med 1998;338:1248-57.
12. Charron P, Dubourg O, Desnos M, Bennaceur M, Carrier L, Camproux AC, et al. Clinical features and prognostic implications of familial hypertrophic cardiomyopathy related to cardiac myosin-binding protein C gene. Circulation 1998;97:2230-6.
13. Moolman JC, Corfield VA, Posen B, Ngumbela K, Seidman C, Brink PA, et al. Sudden death due to troponin T mutations. J Am Coll Cardiol 1997;29:549-55.
14. Thierfelder L, Watkins H, MacRae C, Lamas R, McKenna W, Vosberg HP, et al. Alpha-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: A disease of the sarcomere. Cell 1994;77:701-12.
15. Forissier JF, Carrier L, Farza H, Bonne G, Bercovici J, Richard P, et al. Codon 102 of the cardiac troponin T gene is a putative hot spot for mutations in familial hypertrophic cardiomyopathy. Circulation 1996;94:3069-73.
16. Richard P, Charron P, Leclercq C, Ledeuil C, Carrier L, Dubourg O, et al. Homozygotes for a R869G mutation in the beta-myosin heavy chain gene have a severe form of familial hypertrophic cardiomyopathy. J Mol Cell Cardiol 2000;32:1575-83.
17. Richard P, Isnard R, Carrier L, Dubourg O, Donatien Y, Mathieu B, et al. Double heterozygosity for mutations in the beta-myosin heavy chain and in the cardiac myosin binding protein C genes in a family with hypertrophic cardiomyopathy. J Med Genet 1999;36:542-5.
18. Marian AJ, Yu QT, Workman R, Greve G, Roberts R. Angiotensin-converting enzyme polymorphism in hypertrophic cardiomyopathy and sudden cardiac death. Lancet 1993;342:1085-6.
19. Tesson F, Dufour C, Moolman JC, Carrier L, al-Mahdawi S, Chojnowska L, et al. The influence of the angiotensin I converting enzyme genotype in familial hypertrophic cardiomyopathy varies with the disease gene mutation. J Mol Cell Cardiol 1997;29:831-8.
20. Brugada R, Kelsey W, Lechin M, Zhao G, Yu QT, Zoghbi W, et al. Role of candidate modifier genes on the phenotypic expression of hypertrophy in patients with hypertrophic cardiomyopathy. J Investig Med 1997;45:542-51.
21. Osterop AP, Kofflard MJ, Sandkuijl LA, ten Cate FJ, Krams R, Schalekamp MA, et al. AT1 receptor A/C1166 polymorphism contributes to cardiac hypertrophy in subjects with hypertrophic cardiomyopathy. Hypertension 1998;32:825-30.
22. Durand JB, Abchee AB, Roberts R. Molecular and clinical aspects of inherited cardiomyopathies. Ann Med 1995;27:311-7.
23. Keeling PJ, Gang Y, Smith G, Seo H, Bent SE, Murday V, et al. Familial dilated cardiomyopathy in the United Kingdom. Br Heart J 1995;73:417-21.
24. Marcelis C, et al. Dilated Cardiomyopathy in Cardiovascular Genetics for Clinicians (Doevendans PA and Wilde AA, eds), Kluwer Academic Publishers, 2001, p 155-67.
25. Romano C, Gemme G, Pongiglione R. Aritmie cardiache rare in eta pediatrica. Clin Pediatr 1963;45:656-83.
26. Ward OC. A new familial cardiac syndrome in children. J Irish Med Assoc 1964;54:103-6.
27. Jervell A, Lange-Nielsen F. Congenital deaf-mutism, functional heart disease with prolongation of the Q-T interval and sudden death. Am Heart J 1957;54:59-68.
28. Splawski I, Shen J, Timothy KW, Lehmann MH, Priori S, Robinson JL, et al. Spectrum of mutations in long-QT syndrome genes KVLQT1, HERG, SCN5A, KCNE1, and KCNE2. Circulation 2000;102:1178-85.
29. +-channel dysfunction in an inherited cardiac arrhythmia. Proc Nad Acad Sci U S A 1996;93:2208-12.
30. Clancy CE, Rudy Y. Linking a genetic defect to its cellular phenotype in a cardiac arrhythmia. Nature 1999;400:566-9.
31. Roden DM, Lazzara R, Rosen M, Schwartz PJ, Towbin J, Vincent GM. Multiple mechanisms in the long-QT syndrome. Current knowledge, gaps, and future directions. The SADS Foundation Task Force on LQTS. Circulation 1996;94:1996-2012.
32. Moss AJ, Zareba W, Hall WJ, Schwartz PJ, Crampton RS, Benhorin J, et al. Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome. Circulation 2000;101:616-23.
33. Wilde AA, Roden DM. Predicting the long-QT genotype from clinical data: From sense to science. Circulation 2000;102:2796-8.
34. + channel blockade and to increases in heart rate: Implications for gene-specific therapy. Circulation 1995;92:3381-6.
35. Schwartz PJ, Priori SG, Spazzolini C, Moss AJ, Vincent GM, Napolitano C, et al. Genotype-phenotype correlation in the long-QT syndrome: Gene-specific triggers for life-threatening arrhythmias. Circulation 2001;103:89-95.
36. Zhang L, Timothy KW, Vincent GM, Lehmann MH, Fox J, Giuli LC, et al. Spectrum of ST-T-wave patterns and repolarization parameters in congenital long-QT syndrome: ECG findings identify genotypes. Circulation 2000;102:2849-55.
37. Roden DM. Mechanisms and management of proarrhythmia. Am J Cardiol 1998;82:491-571.
38. Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: A distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll Cardiol 1992;20:1391-6.
39. Hermida JS, Lemoine JL, Aoun FB, Jarry G, Rey JL, Quiret JC. Prevalence of the Brugada syndrome in an apparently healthy population. Am J Cardiol 2000;86:91-4.
40. Chen Q, Kirsch GE, Zhang D, Brugada R, Brugada J, Brugada P, et al. Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature 1998;392:293-6.
41. Priori SG, Napolitano C, Gasparini M, Pappone C, Della Bella P, Giordano U, et al. Natural history of Brugada syndrome: Insights for risk stratification and management. Circulation 2002;105:1342-7.
42. Weiss R, Barmada MM, Nguyen T, Seibel JS, Cavlovich D, Kornblit CA, et al. Clinical and molecular heterogeneity in the Brugada syndrome: A novel gene locus on chromosome 3. Circulation 2002;105:707-13.
43. Schott JJ, Alshinawi C, Kyndt F, Probst V, Hoorntje TM, Hulsbeek M, et al. Cardiac conduction defects associate with mutations in SCN5A. Nat Genet 1999;23:20-1.
44. Veldkamp MW, Viswanathan PC, Bezzina C, Baartscheer A, Wilde AA, Balser JR. Two distinct congenital arrhythmias evoked by a multidysfunctional Na(+) channel. Circ Res 2000;86:E91-7.
45. Laitinen PJ, Brown KM, Piippo K, Swan H, Devaney JM, Brahmbhatt B, et al. Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia. Circulation 2001;103:485-90.
46. Lahat H, Pras E, Olender T, Avidan N, Ben-Asher E, Man O, et al. A missense mutation in a highly conserved region of CASQ2 is associated with autosomal recessive catecholamine-induced polymorphic ventricular tachycardia in Bedouin families from Israel. Am J Hum Genet 2001;69:1378-84.
47. Tiso N, Stephan DA, Nava A, Bagattin A, Devaney JM, Stanchi F, et al. Identification of mutations in the cardiac ryanodine receptor gene in families affected with arrhythmogenic right ventricular cardiomyopathy type 2 (ARVD2). Hum Mol Genet 2001;10:189-94.
48. Li D, Ahmad F, Gardner MJ, Weilbaecher D, Hill R, Karibe A, et al. The locus of a novel gene responsible for arrhythmogenic right-ventricular dysplasia characterized by early onset and high penetrance maps to chromosome 10p12-p14. Am J Hum Genet 2000;66:148-56.
49. Protonotarios N, Tsatsopoulou A, Patsourakos P, Alexopoulos D, Gezerlis P, Simitsis S, et al. Cardiac abnormalities in familial palmoplantar keratosis. Br Heart J 1986;56:321-6.
50. McKoy G, Protonotarios N, Crosby A, Tsatsopoulou A, Anastasakis A, Coonar A, et al. Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease). Lancet 2000;355:2119-24.